Skip Navigation

Filter Results

917 News Releases Found

_
News Releases
1/8/2019

Researchers Awarded $1 Million to Study Optimal Use of Radioactive Drugs for Prostate Cancer Therapy

  • Research
  • Prostate Cancer
Toni Choueiri, MD and David Braun, MD, PhD
News Releases
1/7/2019

Personalized vaccine to be tested for the first time in patients with kidney cancer

  • Research
  • Kidney Cancer
Boston Magazine, January 2019
News Releases
1/2/2019

More than 115 Dana-Farber-affiliated physicians recognized as Top Doctors

David Reardon, MD
News Releases
12/19/2018

Neoantigen vaccine spurs immune response in glioblastoma

  • Research
  • Neuro-oncology
_
News Releases
12/18/2018

James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute

Brandon Mahal, MD
News Releases
12/18/2018

Prostate cancer scoring method may underestimate mortality risk in black men

  • Research
  • Prostate Cancer
News Releases
12/13/2018

Exercise-related hormone irisin found to target key bone cells

  • Research
Jean Zhao, PhD
News Releases
12/11/2018

Study shows PARP inhibitor drugs rouse immune system attack on some ovarian cancers

  • Research
  • Immunotherapy
  • Ovarian Cancer
Nikhil Wagle, MD
News Releases
12/10/2018

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

  • Research
  • Precision Cancer Medicine
  • Metastatic Breast Cancer